CFC launches multi-class policy for medical device market

A syringe is made ready for an injection

CFC Underwriting has launched a product for medical device companies.

BioSurance MD is a multi-class policy targeting key exposures for a wide range of medical device companies involved with the design, development, manufacture or distribution of medical devices of all grades.

Andrew Tamworth, head of life sciences at CFC, said: “This is a unique industry with some very specific exposures and products that can literally mean the difference between life and death.

"Whether making anaesthetic machines or syringes, dentures or stents, these companies need specialist

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

The growing role for brokers in fighting insurance fraud

With reports of fraud escalating in terms of value or number, the role of brokers in combatting these crimes should not be underestimated. Edward Murray looks at the controls, validation tools and processes being implemented to support both detection and prevention.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: